| Biomarker ID | 444 |
| PMID | 19489685 |
| Year | 2009 |
| Biomarker | Differential display 3 (DD3/PCA3) |
| Biomarker Basis | Concentration Based (pg/μl) |
| Biomolecule | mRNA |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in PCa (37 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Benign prostatic hyperplasia (BPH) Vs prostate cancer (PCa) |
| Type of Biomarker | Diagnostic |
| Cohort | 96 age matched patients, 26 with BPH and 70 with Prostate Cancer were included for the study |
| Senstivity | 60% |
| Specificity | 100% |
| AUC | 0.814 95% CI: (0.721–0.886) |
| Accuracy | 70.83 95% CI: (47.8–88.7) |
| Level Of Significance | p=0.0001 |
| Method Used | RT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | PCA3 |